Rossari Biotech — 360° view

Rossari Biotech, a company in the Specialty Chemicals industry, reported revenue of ₹698 crore and net profit of ₹39 crore for the September 2026 quarter.

Rossari Biotech (NSE: ROSSARI) closed at ₹420.90 on 20 Nov 2026, down 32.0% over the past year. Its market capitalisation is ₹2,332 crore and it trades at 15.3 times earnings.

Share price
₹420.90 (20 Nov 2026)
Market cap
₹2,332 Cr (20 Nov 2026)
P/E
15.26 (20 Nov 2026)
Revenue
₹698 Cr (September 2026 quarter)
Net profit
₹39 Cr (September 2026 quarter)
ROCE
13.3% (FY26)
ROE
10.8% (FY26)
Book value
₹254 (FY26)
Dividend yield
0.12% (last 12 months to 20 Nov 2026)
52-week high / low
₹624.00 / ₹375.00 (20 Nov 2026)
1-year return
-32.0% (to 20 Nov 2026)
Sector
Commodities
Industry
Specialty Chemicals
Symbol
NSE: ROSSARI

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.